常茂生物中期报告 2025

ͦ፽ 2 28 1 HH 1228213034 2 34 25,987,000292,922,000524,361,000487,961,00058,581,000 245,020,000168,860,000 • •407,000,000112,362,000 • • • •(1)(2)•• 2.1 3 4 5 8 937,990,000950,745,000 9 10 15%25% (a)200%200% 11 25,790,00018,786,000529,700,000529,700,000 12 13 14 (a) (b) 2,500,000343,500,000183,700,000HHHH 18 (a)68,961,00069,715,00076,315,00078,298,000 (b)60%70%70%168,860,000206,474,0002 (c) (d)36,400,0009,422,000 (e)4.4%4.4%3.1%3.1% (b) 21 22 272,278,000313,802,00013%25,790,00018,786,00037% 12 127A 1. 2. 3. 4. 28%29%72%71% 524,361,000524,540,00019 47,133,00034,719,000 1954.7%53.3%58,581,00057,963,000 53364740,605,00042,389,00040,000,000 5% (b)5% (c)5% 22 25,987,000292,922,000524,361,000487,961,00058,581,000 2168,860,000 2 2 XV(a)XV78(b)352(c)C3(d)622 (a)96,500A135,000,000170,000A100,000B70%2,500,00012,184,000H52,000H(b) (b)73,500A53,000B135,000,000170,000A100,000B30%2,500,00052,000H12,184,000H(a) (c)2,000B135,000,000170,000A100,000B200,00067,500,0006,750,000 (d)66,000,0003,774,000H (e)220,00067,500,0006,750,000 (f)800B135,000,000170,000A100,000B120,00067,500,0006,750,000 (g)2,500,000 ᛆू מᚣ (h)343,500,000 (i)183,700,000H XV(a)XV78(b)352(c)C3(d)622 XV23 XV23336 (a)66,000,0003,774,000H (b)100%62,500,000 XV23336 529,700,000 (a)0.10 (b)0.10 (c)0.10 H H (a) (b) (c) (d) C1 ൚ค H ൚ค